Age-outdated practice of annual screening exams for cervical cancer may be harmful than helpful For years, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer uses . In ’09 2009, nevertheless, accumulating scientific proof led major guideline groupings to agree on a fresh recommendation that females be screened less regularly: every three years rather than each year. Despite the revised guidelines, about 50 percent of the obstetrician-gynecologists surveyed in a recent study said they continue to provide annual examinations – an outdated practice that may be more harmful than useful, said Drs.
The six-month clinical benefit response price was 6/14 or 43 %. Glioma: Ten out of 20 patients with IDH1 mutant positive glioma had stable disease. Four of these patients maintained stable disease for six months or more. The six-month clinical benefit response price was 4/16 or 25 %. Other: One of the four sufferers with additional IDH1 mutant positive solid tumors had steady disease. Trader Webcast and Lunch Info Agios will host an investor lunch time with Dr. Howard Burris today at 1:00 p.m. ET in Boston to examine data provided at the conference. The event will end up being webcast live and may be accessed under ‘Events & Presentations’ in the Investors and Media section of the company's website at A replay of the webcast will be archived on the Agios website for about 30 days following presentation.